HSDT
Solana Company
There isn't enough reported data to score HSDT yet.
HSDT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Unavailable | |
| Unavailable |
HSDT's revenue is currently healthy, but its profitability is weak. There isn't enough data to rate its cash flow and balance sheet.
HSDT PE Valuation
HSDT has no meaningful PE right now: it lost money over the past year.
HSDT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect HSDT's losses to shrink, with revenue growing.
HSDT Earnings Per Share
HSDT is still losing money, but far less than before: $126,750.00 per share over the past year, against $695,625.00 at its worst in mid-2020.
HSDT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.4M | +382% |
| Q2 2026 | $2.5M | +5774% |
| Q1 2026 | $3.6M | +7290% |
| Q4 2025 | $5.2M | +3339% |
| Q3 2025 | $697K | +1267% |
| Q2 2025 | $43K | -76% |
| Q1 2025 | $49K | -64% |
| Q4 2024 | $152K | +13% |
HSDT's revenue has grown year over year for five quarters in a row: $3M last quarter, up 382% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3091% | +8177 points |
| Q2 2026 | -1293% | +6432 points |
| Q1 2026 | -2751% | +5435 points |
| Q4 2025 | -3846% | -1775 points |
| Q3 2025 | -5086% | +2894 points |
| Q2 2025 | -7726% | -5929 points |
| Q1 2025 | -8186% | -5655 points |
| Q4 2024 | -2070% | -394 points |
HSDT's operating margin was 3091% last quarter, up 8177 points from the same quarter a year ago, near the top of its range since 2019.
HSDT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | -$2.4M | -$341K |
| Q3 2024 | -$2.8M | -$313K |
| Q2 2024 | -$2.9M | -$150K |
| Q1 2024 | -$3M | +$203K |
| Q4 2023 | -$2M | +$104K |
| Q3 2023 | -$2.5M | +$1.4M |
| Q2 2023 | -$2.7M | +$933K |
| Q1 2023 | -$3.2M | +$1.5M |
HSDT has burned cash in almost every quarter: −$22M over the past year, against −$11M the year before.
HSDT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +102% | +5.1K shares |
| 1 year | +1032% | +9.2K shares |
| 3 years | +18557% | +10K shares |
HSDT has 10,075 diluted shares, up 1032% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.8M |
| Q2 2026 | $2.3M |
| Q1 2026 | $3.5M |
HSDT Net Leverage
HSDT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HSDT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.0 | Neutral |
| Stochastic | 19.6 | Oversold |
HSDT's weekly RSI is 33 (neutral) and its Stochastic is 20 (oversold).
HSDT PE vs Healthcare Sector
HSDT has no meaningful PE right now: it lost money over the past year.
HSDT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.30 | 18% below |
| 20 week MA | $2.10 | 10% below |
| 50 week MA | $2.24 | 16% below |
| 100 week MA | $91.2 | 98% below |
| 200 week MA | $2,397.1 | 100% below |
HSDT is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
HSDT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1,246,875.0 | $540,750.0 | -57% |
| 2021 | $540,750.0 | $208,500.0 | -61% |
| 2022 | $208,500.0 | $8,325.0 | -96% |
| 2023 | $8,325.0 | $6,030.0 | -28% |
| 2024 | $6,030.0 | $525.0 | -91% |
| 2025 | $525.0 | $2.78 | -99% |
| 2026 YTD | $2.78 | $1.89 | -32% |
HSDT has finished every year since 2020 lower, and it's down 32% so far in 2026.